The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease
Abstract
OBJECTIVE: To validate an in vivo method for mapping acetylcholinesterase (AChE) activity in human brain, preparatory to monitoring inhibitor therapy in AD. BACKGROUND: AChE activity is decreased in postmortem AD brain. Lacking a reliable in vivo measure, little is known about central activity in early AD, when the disease is commonly targeted by AChE inhibitor drug therapy. METHODS: Intravenous N-[11C]methylpiperidin-4-yl propionate ([11C]PMP) served as an in vivo AChE substrate. AChE activity was defined using cerebral PET for tracer kinetic estimates of the local rate of [11C]PMP hydrolysis in 26 normal controls and 14 patients with AD. Eleven AD patients also had concomitant in vivo cerebral measures of vesicular acetylcholine transporter (cholinergic terminal) density and glucose metabolism. RESULTS: Cerebral AChE activity measures 1) were independent of changes in tracer delivery to cerebral cortex; 2) agreed with reported postmortem data concerning normal relative cerebral distributions, absence of large age-effect in normal aging, and deficits in AD; 3) correlated in AD cerebral cortex with concomitant in vivo measures of cholinergic terminal deficits, but not with metabolic deficits; and 4) agreed quantitatively with predicted level of cerebral AChE inhibition induced by physostimine. CONCLUSIONS: This in vivo PET method provided valid measures of central AChE activity in normal subjects and AD patients. Applied in early AD, it should facilitate inhibitor treatment by confirming central inhibition, optimizing drug dosage, identifying likely responders, and testing surrogate markers of therapeutic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Multimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
Self-citationAnatomic standardization: linear scaling and nonlinear warping of functional brain images.
Minoshima, S., Koeppe, R. A., Frey, K. A., & Kuhl, D. E. (1994) · PubMed · Cited by 404
Self-citationDistribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study
Brun, A., & Gustafson, L. (1976) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00367450 · Cited by 397
Regional cerebral blood flow and oxygen consumption in human aging
Pantano, P., Baron, J. C., Lebrun-Grandié, P., Duquesnoy, N., Bousser, M. G., & Comar, D. (1984) · Stroke · doi:10.1161/01.str.15.4.635 · Cited by 341
The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system
Decker, M. W. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90007-5 · Cited by 323
Automatic detection of brain contours in MRI data sets
Brummer, M. E., Mersereau, R. M., Eisner, R. L., & Lewine, R. R. J. (1993) · IEEE Transactions on Medical Imaging · doi:10.1109/42.232244 · Cited by 297
Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Suzuki, K., & Irie, T. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09124-6 · Cited by 259
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
Albin, R. L., Minoshima, S., D'Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. F. (1996) · Neurology · doi:10.1212/wnl.47.2.462 · Cited by 241
Self-citationBird, T. D., Stranahan, S., Sumi, S. M., & Raskind, M. (1983) · Annals of Neurology · doi:10.1002/ana.410140306 · Cited by 222
Atack, J. R., Perry, E. K., Bonham, J. R., Candy, J. M., & Perry, R. H. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02858.x · Cited by 194
Convergent cholinergic activities in aging and Alzheimer's disease
Perry, E. K., Johnson, M. H., Kerwin, J. M., Piggott, M. A., COURT, J. A., Shaw, P. J., Ince, P. G., Brown, A. J., & Perry, R. H. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90113-c · Cited by 155
Рапопорт, С. И. (1991) · PubMed · Cited by 141
Irie, T., Fukushi, K., Akimoto, Y., Tamagami, H., & Nozaki, T. (1994) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)90159-7 · Cited by 119
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.
Kuhl, D. E., Koeppe, R. A., Fessler, J. A., Minoshima, S., Ackermann, R. J., Carey, J. E., Gildersleeve, D. L., Frey, K. A., & Wieland, D. M. (1994) · PubMed · Cited by 117
Self-citationKilbourn, M. R., Snyder, S. E., Sherman, P. S., & Kuhl, D. E. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199602)22:2<123::aid-syn5>3.0.co;2-f · Cited by 111
Self-citationCholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
Reinikainen, K. J., Riekkinen, P. J., Palj�rvi, L., Soininen, H., Helkala, E.-L., Jolkkonen, J., & Laakso, M. P. (1988) · Neurochemical Research · doi:10.1007/bf00973325 · Cited by 104
Irie, T., Fukushi, K., Namba, H., Iyo, M., Tamagami, H., Nagatsuka, S., & Ikota, N. (1996) · PubMed · Cited by 95
Mesulam, M. M., & Geula, C. (1992) · Brain Research · doi:10.1016/0006-8993(92)90543-i · Cited by 93
Holthoff‐Detto, V., Koeppe, R. A., Frey, K. A., Paradise, A. H., & Kuhl, D. E. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.131 · Cited by 93
Self-citationSokoloff, L. (1981) · Profiles in Science · Cited by 80
Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease*
Asthana, S., Greig, N. H., Hegedũs, L., Holloway, H. W., Raffaele, K. C., Schapiro, M. B., & Soncrant, T. T. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90246-5 · Cited by 67
Snyder, S. E., Tluczek, L. J. M., Jewett, D. M., Nguyen, T. B., Kuhl, D. E., & Kilbourn, M. R. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00045-6 · Cited by 56
Self-citationQuantitation of Cholinergic Synaptosomes from Guinea Pig Brain
Richardson, P. J. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb05319.x · Cited by 52
Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
Somani, S. M., & Khalique, A. (1987) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06796-0 · Cited by 51
The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared
Gsell, W., Strein, I., & Riederer, P. F. (1996) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6892-9_5 · Cited by 44
Lateralization of Brain Morphologic and Cholinergic Abnormalities in Alzheimer's Disease
Moossy, J. J., Zubenko, G. S., Martinez, A. J., Rao, G. R., Kopp, U., & Hanin, I. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420059023 · Cited by 39
Zubieta, J., Koeppe, R. A., Mulholland, G. K., Kuhl, D. E., & Frey, K. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199806000-00004 · Cited by 39
Self-citationPreserved acetylcholinesterase activity in aged cerebral cortex
Namba, H., lyo, M., Shinotoh, H., Nagatsuka, S.-I., Fukushi, K., & Irie, T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70293-2 · Cited by 36
Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol
Dort, M. E. V., Jung, Y., Gildersleeve, D. L., et al. (1993) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(93)90093-a · Cited by 33
Research works printed but not linked: 4
- Geula C Mesulam M-M. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Terry RD Katzman R Bick KL eds. Alzheimer disease. New York: Raven Press 1994.
- Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Mapping acetylcholinesterase in human brain using PET and N-[C-11]methylpiperidinyl propionate (PMP). J Nucl Med 1996;37 (5):21P.
- Hara M, Minoshima S, Foster NL, Kuhl DE. Is regional cerebral blood flow coupled with glucose metabolism in Alzheimer’s disease? J Nucl Med 1993;34 (5):116P.
- Friedland RP, Brun A, Budinger TF. Pathological and PET correlations in Alzheimer’s disease. Lancet 1985;1:228.
Cited by
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
The cognitive neuroscience of sustained attention: where top-down meets bottom-up.
Sarter, M., Givens, B., & Bruno, J. P. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00044-3 · Cited by 1,194
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
Miller, P. W., Long, N. J., Vilar, R., & Gee, A. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800222 · Cited by 894
Metadata
- Authors
- Kuhl, D. E., Koeppe, R. A., Minoshima, S., Snyder, S. E., Ficaro, E. P., Foster, N. L., Frey, K. A., & Kilbourn, M. R.
- Venue
- Neurology
- Published
- 1999-03
- Volume
- 52
- Issue
- 4
- Pages
- 691-691
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2048755200
- Cited by
- 387
- References
- 36
- FWCI
- 14.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.